During the past 12 months, Ligand Pharmaceuticals's average Book Value per Share Growth Rate was 13.30% per year.
During the past 3 years, the average Book Value per Share Growth Rate was -3.30% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 3.70% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 35.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Ligand Pharmaceuticals was 145.10% per year. The lowest was -56.90% per year. And the median was 24.80% per year.
Competitive Comparison of Ligand Pharmaceuticals's 3-Year Book Growth Rate
For the Biotechnology subindustry, Ligand Pharmaceuticals's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ligand Pharmaceuticals's 3-Year Book Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ligand Pharmaceuticals's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Ligand Pharmaceuticals's 3-Year Book Growth Rate falls into.
Ligand Pharmaceuticals 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
Ligand Pharmaceuticals (NAS:LGND) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Ligand Pharmaceuticals 3-Year Book Growth Rate Related Terms
Thank you for viewing the detailed overview of Ligand Pharmaceuticals's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Ligand Pharmaceuticals (Ligand Pharmaceuticals) Business Description
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LGND has been successfully added to your